Joengbin Ahn
Director Of Communications at Bridge Biotherapeutics, Inc. | Seoul, Seoul, South Korea, Republic of Korea
Joengbin Ahn’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Director Of Communications at Bridge Biotherapeutics, Inc. in August 2018 - Present
Communication Specialist at Pharmaresearch Products in August 2016 - August 2018
Senior Account Executive at Edelman in September 2014 - May 2016
Account Executive at Waggener Edstrom Worldwide (Shout Korea) in December 2012 - August 2014
Intern at U.S. Commercial Service in January 2012 - June 2012
Harvard Medical School Postgraduate Medical Education, June 2022 to June 2023
Aalto University, January 2019 to January 2021
서강대학교, January 2008 to January 2013
Bridge Biotherapeutics Inc., based in the Republic of Korea, US, and China, is a publicly-traded clinical-stage biotech company founded in 2015. Bridge Biotherapeutics is engaged in the discovery and development of novel therapeutics, focusing on therapeutic areas with high unmet needs such as ulcerative colitis, fibrotic diseases, and cancers. The company is developing BBT-401, a first-in-class Pellino-1 inhibitor for the treatment of ulcerative colitis, BBT-877, a novel autotaxin inhibitor for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF), and BBT-176, a potent targeted cancer therapy for non-small cell lung cancer (NSCLC) with C797S triple EGFR mutations.
Discover more about Bridge Biotherapeutics, Inc.
Senior VP, Head of Corporate Development
Senior VP, Head of Corporate Development at Bridge Biotherapeutics, Inc.
(February 2023 – Present)
Director, Head of Pharmacovigilance at Bridge Biotherapeutics
Director, Head of Pharmacovigilance at Bridge Biotherapeutics, Inc.
(December 2021 – Present)
Medicinal Chemist | Drug Hunter
Principal Scientist, Medicinal Chemistry at DeepCure
(August 2024 – Present)
Doctor of Pharmacy (Pharm.D.)
Therapeutic Strategy Manager at Novotech
(November 2023 – Present)
COL & QL at Bridge Biotherapheutics.
Director, Clinical Operation & Quality Lead at Bridge Biotherapeutics, Inc.
(March 2023 – Present)
Director, Clinical Trial Leader
Director, Clinical Trial Leader at Bridge Biotherapeutics, Inc.
(April 2022 – Present)
What is Joengbin Ahn email address?
Email Joengbin Ahn at [email protected] and [email protected]. This email is the most updated Joengbin Ahn's email found in 2026.
How to contact Joengbin Ahn?
To contact Joengbin Ahn send an email to [email protected] or [email protected].
What company does Joengbin Ahn work for?
Joengbin Ahn works for Bridge Biotherapeutics, Inc..
What is Joengbin Ahn's role at Bridge Biotherapeutics, Inc.?
Joengbin Ahn is Director Of Communications
What industry does Joengbin Ahn work in?
Joengbin Ahn works in the Public Relations & Communications industry.
